Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × eribulin × Clear all

Phase

Phase 2 39 Phase 1/2 12 Phase 3 10 Phase 1 10 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

enzalutamide 8 Saline Solution 8 Docetaxel 8 nilotinib 7 Fentanyl 7 Everolimus 7 Cyclophosphamide 7 Bupivacaine 7 Paclitaxel 6 Carboplatin 6 Bevacizumab 6 Sodium Chloride 5 Lidocaine 5 Letrozole 5 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5 Dexamethasone 5 Capecitabine 5 fludarabine 4 Trastuzumab 4 Tranexamic Acid 4 Tobacco Use Cessation Devices 4 Surveys and Questionnaires 4 Rituximab 4 Oxycodone 4 Nivolumab 4 Morphine 4 Leuprolide 4 Ipilimumab 4 Gefitinib 4 Aprepitant 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01961544 2016-10-07

ESKIMO

Eisai Inc.

Phase 4 Completed

101 enrolled 6 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡